Simulations Plus, Inc. (NASDAQ:SLP) Shares Sold by Invesco Ltd.

Invesco Ltd. cut its holdings in Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 7.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 411,002 shares of the technology company's stock after selling 33,931 shares during the period. Invesco Ltd. owned about 2.05% of Simulations Plus worth $11,463,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Wells Fargo & Company MN increased its position in shares of Simulations Plus by 16.1% during the fourth quarter. Wells Fargo & Company MN now owns 41,161 shares of the technology company's stock worth $1,148,000 after purchasing an additional 5,704 shares in the last quarter. Pitcairn Co. increased its position in shares of Simulations Plus by 10.8% during the fourth quarter. Pitcairn Co. now owns 7,310 shares of the technology company's stock worth $204,000 after purchasing an additional 711 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of Simulations Plus by 210.7% during the fourth quarter. JPMorgan Chase & Co. now owns 147,154 shares of the technology company's stock worth $4,104,000 after purchasing an additional 99,789 shares in the last quarter. Summitry LLC acquired a new stake in shares of Simulations Plus during the fourth quarter worth about $2,385,000. Finally, LPL Financial LLC acquired a new stake in shares of Simulations Plus during the fourth quarter worth about $230,000. 78.08% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

SLP has been the topic of a number of research analyst reports. StockNews.com upgraded Simulations Plus from a "sell" rating to a "hold" rating in a research report on Monday. KeyCorp raised their price target on Simulations Plus from $32.00 to $40.00 and gave the stock an "overweight" rating in a report on Wednesday, April 16th. Finally, William Blair reissued an "outperform" rating on shares of Simulations Plus in a report on Wednesday, January 8th. Two research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $50.00.

Insider Buying and Selling

In related news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $33.91, for a total transaction of $678,200.00. Following the completion of the sale, the director now owns 3,402,584 shares in the company, valued at approximately $115,381,623.44. This trade represents a 0.58 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 19.40% of the stock is currently owned by company insiders.

Simulations Plus Stock Down 0.8 %

Shares of Simulations Plus stock traded down $0.29 during trading on Monday, reaching $35.21. The company's stock had a trading volume of 251,809 shares, compared to its average volume of 199,721. The business has a 50 day moving average price of $28.42 and a 200-day moving average price of $30.29. The company has a market capitalization of $708.11 million, a P/E ratio of 88.03 and a beta of 1.13. Simulations Plus, Inc. has a 12-month low of $23.01 and a 12-month high of $51.22.

Simulations Plus (NASDAQ:SLP - Get Free Report) last released its quarterly earnings data on Thursday, April 3rd. The technology company reported $0.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.06. Simulations Plus had a return on equity of 6.84% and a net margin of 10.97%. The firm had revenue of $22.43 million during the quarter, compared to analysts' expectations of $21.93 million. During the same quarter in the prior year, the business posted $0.20 earnings per share. Simulations Plus's revenue was up 22.5% compared to the same quarter last year. Research analysts predict that Simulations Plus, Inc. will post 1.09 EPS for the current fiscal year.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.